Hematopoietic stem cell transplantation for inborn errors of immunity: 30-year single-center experience

Hematopoietic stem cell transplantation for inborn errors of immunity: 30-year single-center experience

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) represents an effective treatment for a variety of inborn errors of immunity (IEI). We report the experience of children affected by IEI who received allo-HSCT over a period of 32 years at IRCCS Istituto Giannina Gaslini, Genoa, Italy. H...

Full description

Bibliographic Details
Main Authors:	Gianluca Dell’Orso, Francesca Bagnasco, Stefano Giardino, Filomena Pierri, Giulia Ferrando, Daniela Di Martino, Concetta Micalizzi, Daniela Guardo, Stefano Volpi, Federica Sabatini, Maurizio Miano, Marco Gattorno, Carlo Dufour, Maura Faraci
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-02-01
Series:	Frontiers in Immunology
Subjects:	hematopoietic stem cell transplantation inborn errors of immunity primary immunodeficiency graft-versus-host disease haploidentical TCR αβ/CD19+-depleted transplant
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1103080/full

Similar Items

Role of αβ T Cell Depletion in Prevention of Graft versus Host Disease
by: Haitham Abdelhakim, et al.
Published: (2017-06-01)

Successful HLA haploidentical myeloablative stem cell transplantation for aggressive hepatosplenic alpha/beta (αβ) T-cell lymphoma
by: Gioacchino Catania, et al.
Published: (2014-01-01)

Repeated haploidentical allogeneic hematopoietic stem cell transplantation with TCR αβ/CD19 depletion in patient with primary myelofibrosis. Case report
by: Elmira I. Kolgaeva, et al.
Published: (2021-07-01)

Immune Modulation Properties of Zoledronic Acid on TcRγδ T-Lymphocytes After TcRαβ/CD19-Depleted Haploidentical Stem Cell Transplantation: An analysis on 46 Pediatric Patients Affected by Acute Leukemia
by: Pietro Merli, et al.
Published: (2020-05-01)

CD3/CD19 Depletion for T-cell Reduction of Allogeneic Transplants: Mostly Efficient, but not Robust
by: Eliza Wiercinska, et al.
Published: (2021-08-01)

Human γδ T-Cells: From Surface Receptors to the Therapy of High-Risk Leukemias
by: Vito Pistoia, et al.
Published: (2018-05-01)

Antithymocyte Globulin Plus Post-Transplant Cyclophosphamide Combination as an Effective Strategy for Graft-versus-Host Disease Prevention in Haploidentical Peripheral Blood Stem Cell Transplantation for Children with High-Risk Malignancies
by: Kang-Hsi Wu, et al.
Published: (2022-11-01)

Graft-versus-host disease and other cutaneous manifestations in pediatric patients transplanted for Fanconi anemia
by: Leane Dhara Dalle Laste, et al.
Published: (2023-07-01)

Haploidentical Stem Cell Transplantation in Lymphomas—Expectations and Pitfalls
by: Jacopo Mariotti, et al.
Published: (2020-11-01)

Impact of graft-versus-host disease prophylaxis on immune reconstitution in patients after allogeneic hematopoietic stem cell transplantation
by: E. D. Mikhaltsova, et al.
Published: (2021-11-01)

Hepatic-Based Inborn Errors of Metabolism
by: Tormod Lund
Published: (2015-01-01)

Characterization of Bovine Intraepithelial T Lymphocytes in the Gut
by: Akanksha Hada, et al.
Published: (2023-09-01)

Haploidentical stem cell transplant: Established treatment, expanding horizons
by: Mukul Aggarwal, et al.
Published: (2016-01-01)

Inborn Errors of the Immune System Associated With Atopy
by: Ryan W. Nelson, et al.
Published: (2022-04-01)

Haploidentical Stem Cell Transplantation for Hematological Disorders: Real-World Experience from India
by: Pallavi Mehta, et al.

Mother and child T cell receptor repertoires: deep profiling study
by: Ekaterina V Putintseva, et al.
Published: (2013-12-01)

Low-dose ATG combined with low-dose PTCY in preventing GVHD after haploidentical transplantation: a retrospective analysis of 90 cases
by: LEI Jinmei, et al.
Published: (2024-02-01)

Post-transplant cyclophosphamide or cell selection in haploidentical allogeneic hematopoietic cell transplantation?
by: Razan Mohty, et al.
Published: (2024-12-01)

Sirolimus versus cyclosporine in haploidentical stem cell transplantation with posttransplant cyclophosphamide and mycophenolate mofetil as graft‐versus‐host disease prophylaxis
by: Rafael Hernani, et al.
Published: (2021-05-01)

Automatic generation of alloreactivity-reduced donor lymphocytes and hematopoietic stem cells from the same mobilized apheresis product
by: E. Wiercinska, et al.
Published: (2023-11-01)

Influence of ABO compatibility on haploidentical hematopoietic stem-cell transplant
by: Rajesh B Sawant, et al.
Published: (2023-01-01)

Delayed kidney transplantation after HLA-haploidentical hematopoietic cell transplantation in a young woman with myelodysplastic syndrome with renal failure
by: Kevin C. Miller, et al.
Published: (2022-01-01)

TCR Recognition of Peptide–MHC-I: Rule Makers and Breakers
by: Christopher Szeto, et al.
Published: (2020-12-01)

Outcomes of Bone Marrow Compared to Peripheral Blood for Haploidentical Transplantation
by: Nidhi Sharma, et al.
Published: (2021-06-01)

Haploidentical Stem Cell Transplantation for Acute Myeloid Leukemia: Current Therapies, Challenges and Future Prospective
by: Ying-Jun Chang, et al.
Published: (2021-10-01)

Low-dose post-transplant cyclophosphamide and anti-thymocyte globulin as an effective strategy for GVHD prevention in haploidentical patients
by: Yu Wang, et al.
Published: (2019-09-01)

Two dose levels of rabbit antithymocyte globulin as graft-versus-host disease prophylaxis in haploidentical stem cell transplantation: a multicenter randomized study
by: Ren Lin, et al.
Published: (2019-08-01)

Unrelated umbilical cord blood can improve the prognosis of haploidentical hematopoietic stem cell transplantation
by: Ying Yang, et al.
Published: (2022-09-01)

Lymphoproliferation in Inborn Errors of Immunity: The Eye Does Not See What the Mind Does Not Know
by: Saniya Sharma, et al.
Published: (2022-05-01)

The Critical and Diverse Roles of CD4–CD8– Double Negative T Cells in Nonalcoholic Fatty Liver DiseaseSummary
by: Changying Li, et al.
Published: (2022-01-01)

Chimerism Revisited: Perspective of an Immunopathologist
by: Devika Gupta, et al.
Published: (2023-06-01)

Association between gene polymorphisms in the cyclophosphamide metabolism pathway with complications after haploidentical hematopoietic stem cell transplantation
by: Paula Muñiz, et al.
Published: (2022-09-01)

Hematopoietic Stem Cell Transplantation in Inborn Errors of Metabolism
by: Emily Y. Tan, et al.
Published: (2019-10-01)

Strategies in Haploidentical Stem Cell Transplantation in Adults
by: Ulaş D. Bayraktar, et al.
Published: (2013-12-01)

Increased risk of 100-day and 1-year infection-related mortality and complications in haploidentical stem cell transplantation
by: Chang J, et al.
Published: (2019-05-01)

Epigenetic Alterations in Inborn Errors of Immunity
by: Roberta Romano, et al.
Published: (2022-02-01)

Case Series Using Salvage Haplo-Identical Stem Cells for Secondary Transplantation
by: Alexandra Ionete, et al.
Published: (2023-06-01)

Is Post-Transplant Cyclophosphamide the New Methotrexate?
by: Alberto Mussetti, et al.
Published: (2021-08-01)

Low-dose anti-thymocyte globulin plus low-dose post-transplant cyclophosphamide-based regimen for prevention of graft-versus-host disease after haploidentical peripheral blood stem cell transplants: a large sample, long-term follow-up retrospective study
by: Xingying Li, et al.
Published: (2023-10-01)

The Presence of a CMV Immunodominant Allele in the Recipient Is Associated With Increased Survival in CMV Positive Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation
by: Dolores Grosso, et al.
Published: (2019-09-01)